SI-BONE, Inc. Share Price Börse Stuttgart

Equities

2K3

US8257041090

Medical Equipment, Supplies & Distribution

Real-time Estimate Tradegate 12:45:15 20/05/2024 pm IST 5-day change 1st Jan Change
13.75 EUR +0.36% Intraday chart for SI-BONE, Inc. -4.20% 0.00%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 17Cr 15Cr 1.38TCr Sales 2025 * 19Cr 18Cr 1.62TCr Capitalization 61Cr 57Cr 5.12TCr
Net income 2024 * -3.9Cr -3.59Cr -324.64Cr Net income 2025 * -3.3Cr -3.04Cr -274.7Cr EV / Sales 2024 * 3.13 x
Net cash position 2024 * 9.74Cr 8.97Cr 811.04Cr Net cash position 2025 * 8.7Cr 8.01Cr 724.43Cr EV / Sales 2025 * 2.71 x
P/E ratio 2024 *
-15.6 x
P/E ratio 2025 *
-19 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 97.86%
More Fundamentals * Assessed data
Dynamic Chart
1 week-4.20%
Current month+3.79%
1 month-4.86%
3 months-29.02%
More quotes
1 week
13.40
Extreme 13.4
14.10
1 month
12.90
Extreme 12.9
14.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 26/15/26
Founder 69 18/08/18
Director of Finance/CFO 44 19/21/19
Members of the board TitleAgeSince
Founder 69 18/08/18
Director/Board Member 70 01/13/01
Director/Board Member 77 01/11/01
More insiders
Date Price Change
20/24/20 13.6 -0.73%
17/24/17 13.7 -0.72%
16/24/16 13.8 +0.73%
15/24/15 13.7 +0.74%
14/24/14 13.6 -1.45%

Delayed Quote Börse Stuttgart, May 20, 2024 at 11:38 am IST

More quotes
SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
14.92 USD
Average target price
25.56 USD
Spread / Average Target
+71.28%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW